Published 2 years ago

Canada OKs Pfizer’s bivalent booster targeting Omicron subvariants

Summary by Ground News

Canada on Friday authorised updated COVID-19 booster shots from Pfizer Inc and its partner BioNTech SE that target the Omicron BA.4 and BA.5 subvariants, according to the government's website. The booster shot, which has been authorised for people 12 years and older, is the second to get clearance from Health Canada after Moderna Inc's modified booster last month.

0 Articles

All

Left

Center

Right

CTV News

Health Canada authorizes Pfizer-BioNTech BA.4/BA.5 Omicron vaccine

Health Canada says Canadians ages 12 and up can now be given the Pfizer-BioNTech COVID-19 booster vaccine that targets the BA.4 and BA.5 strains of the Omicron variant.

2 years ago·Canada

Read Full Article

Reuters

Canada authorises Pfizer's Omicron retooled booster

Canada on Friday authorised updated COVID-19 booster shots from Pfizer Inc and its partner BioNTech SE that target the Omicron BA.4 and BA.5 subvariants, according to the government's website.

2 years ago·United Kingdom

Read Full Article

CBC News

Health Canada approves Pfizer's new bivalent COVID-19 vaccine

Health Canada has approved Pfizer's new bivalent COVID-19 vaccine for use as a booster dose in those aged 12 and up.

2 years ago·Canada

Read Full Article

Global News

Canada OKs Pfizer’s bivalent booster targeting Omicron subvariants

Health Canada announced Friday it has approved the updated shot, which has been designed to target Omicron’s BA.4 and BA.5 subvariants.

2 years ago·Toronto, Canada

Read Full Article

The Toronto Star

Health Canada approves Pfizer’s BA.4/BA.5 Omicron vaccine

Health Minister Jean-Yves Duclos and Health Canada officials are scheduled to discuss the approval in detail later today.

2 years ago·Toronto, Canada

Read Full Article

The Epoch Times

Canada Authorises Pfizer's Omicron Retooled Booster

Canada on Friday authorised updated COVID-19 booster shots from Pfizer Inc and its partner BioNTech SE that target the Omicron BA.4 and BA.5 subvariants, according to the government’s website. Pfizer and BioNTech said in a joint statement the companies will make “significant volumes of the vaccine available in the coming days”. The booster shot, which has been authorised for people 12 years and older, is the second to get clearance from Health C…

2 years ago·New York, United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.